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Abstract
Background: Primary open angle glaucoma is one of the leading causes of avoidable
blindness in Sub-Saharan Africa
Medical therapy: Anti-glaucoma medication pose a special challenge due to high cost,
non availability, and presence of sub- standard/ adulterated drugs in the region. With
wide spread poverty compliance to medication for life is poor.
Trabeculectomy: Although there are various types of glaucoma surgeries, trabecu‐
lectomy with use of anti-fibrotic agent is found to offer good intra ocular pressure
control among patients in the region. The use of anti-fibrotic agents like mitomycin-
C and 5 Flourouracil becomes necessary due to the tendency of pigmented African
eye to form scar that results in bleb failure.
Conclusion: Trabeculectomy with intra operative use of anti metabolite is an
acceptable choice in treatment of primary open angle glaucoma in sub-Saharan Africa.
The key to success is adequate pre operative patient education on the goal of
treatment.
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1. Introduction
Glaucoma is a group of disorders manifesting characteristic progressive optic nerve damage
and is associated with many risk factors such as central corneal thickness, structure of the optic
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nerve head, age, genetic factors, race and intraocular pressure (IOP). Primary open angle
glaucoma (POAG) is not associated with any other cause. The features include characteristic
optic nerve damage, nerve fibre layer loss, visual field changes and an open angle on gonio‐
scopy. The global estimate of glaucomatous optic neuropathy is 60 million and 8.4 million turn
blind from the disease. The highest prevalence of POAG occurs in Africans.[1] In the sub-
Saharan African (SSA) region there is shortage of population studies on causes of blindness.
POAG is under-reported as the mechanism for making a diagnosis is difficult under circum‐
stances in which field surveys are conducted. Local and regional studies have demonstrated
the contribution of glaucoma as a major cause of avoidable blindness in SSA.[2-9, 21] There
are peculiarities in the way glaucoma is present in the region. These factors are related to the
individual, the family, the community and the health-care system. Initially POAG has subtle
nature of presentation with symptoms such as pain which is a major driving force for seeking
medical help being largely absent. Poor access to health care in general and eye care in
particular, superstition and inequity in distribution of human and material resources in eye
care result in the largely rural population having minimal access.[10] Even where some level
of eye care services are available, basic equipment such as tonometer, visual field analyser, slit
lamp and relevant diagnostic lenses are unavailable. The few eye care personnel available are
not motivated to work in the rural areas as basic services like good schools; tap water and
electricity are not steadily supplied. Patients are left at the mercy of quacks including tradi‐
tional eye healers (TEH) whose unregulated practices contribute to increase in the burden of
avoidable blindness. TEH dispense traditional eye medicine (TEM) of unknown contents, not
produced under aseptic conditions and can result in corneal damage and blindness.[11]
Patients often present late with advanced optic nerve damage and are visually impaired.[12,
13, 14, 15, 16] One can deduce that only a small fraction of POAG patients make it to the few
available centres where quality care can be offered.
2. The argument in favour of POAG surgery
The risk factor most amenable to control is IOP. There are two broad approaches to treatment,
which can be surgical or medical. One cannot draw a line between the options, with various
permutations and combinations possible in order to achieve success. Even where a decision is
reached to do surgery there is need for initial medication to reduce the IOP. Treatment and
monitoring is for life. Potent glaucoma medications are expensive with most patients being
poor and defendant. Quality and safety is often suspected as adulterated medications float the
markets in SSA. Medicines are conveyed in open trucks under the scorching sun or left in the
open. Even quality medicine will eventually loose potency before getting to the patients. The
few reputable pharmaceutical vendors are located in major cities and townships away from
the reach of rural poorPoverty and illiteracy hinder compliance with treatment. The health
insurance scheme is for the regular sectors of the economy, accessible to only civil servants
and those working for the organized private sector. Bulk of the population has no health
insurance cover and need to pay for eye care at the point of service delivery. Inability to pay
results in denial of service. Such denial of access to eye care services is against the goals of
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Vision 2020: the right to sight. These multitudes of factors make a case for surgery. As clinicians
in the SSA region search for better treatment compliance, they move closer to surgery.[17]
Considering the unavailability of potent, cost-effective, long-term acceptable medications,
surgery can be a worthwhile option.[18] Successful surgery can be a one off expenses alterna‐
tive. It ensures reduction in IOP round the clock. The patient needs not to remember that it’s
time to apply the eye drop and is free from local and systemic side effects. The key to surgical
success is proper patient’s education and counselling. POAG patients are often admitted to
the same ward with blind cataract patients. A day after surgery pseudo-phakic patients move
around unaided. Glaucoma patient expects the same outcome. Thus, without proper patient
education, the seed of discontentment and dissatisfaction is sown. Glaucoma patients need to
be educated on the purpose of surgery and its impact on vision. They need to know that the
procedure is not free of complications and may accelerate cataract formation resulting in
additional surgery at a later date. POAG patients are to be informed that surgery can fail or
be partially successful in IOP control warranting reintroduction of eye medications. Penetrat‐
ing glaucoma surgery mainly trabeculectomy with antimetabolite is the most common
procedure performed with encouraging outcome.[19] Trabeculectomy records various success
rates at given time intervals after surgery.[19, 20, 21, 22] IOP control appears to be lower when
surgery is performed without antimetabolite.[22] Releasable sutures offer additional advant‐
age in reducing IOP in the early post-operative period.[23] Other non-penetrating procedures
such as visco-canalostomy and trabeculoplasty are not done routinely. Laser procedures
including argon or diode laser trabeculoplasty generally do not give very encouraging
outcomes in pigmented African eyes. Where available, laser can be used to augment medical
treatment/surgery on a case by case basis.
3. Preoperative management
Patient education is a crucial step in administration of informed consent. Patient and caregiver
need to know the status of the patient’s vision, the type of procedure to be performed, the goal
to be achieved, post-operative medication/management and the possibility that glaucoma
drugs may be reinstated after surgery even if partially. The current visual acuity, visual field,
tonometry, retinal nerve fibre layer thickness (RNFL) measurements and gonioscopic finding
should be available and form frame work of the counselling. Clinicians are often reluctant to
do surgery on those with advanced/end-stage glaucoma characterized by ‘tunnel visual fields’,
severe visual impairment and vertical optic disc cupping of 0.9 or worse. Reluctance is related
to risk of further sight deterioration which could be attributed to post-operative inflammation,
post-operative complications such as endophthalmitis (though rare) or increase in lenticular
opacity and the risk of visual wipe out phenomenon. Patients’ and caregivers’ knowledge of
the goal of controlling IOP and by so doing limiting optic nerve damage will reduce complains
that ‘doctor you have operated my eyes and yet my sight has not improved’. Preoperative
routine includes medical treatment to reduce the IOP to lower teens and trimming of the eye
lashes. Blood pressure (BP) and fasting blood sugar (FBS) levels are measured to identify
undiagnosed hypertension and those with diabetes mellitus. BP and FBS control are essential
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before, during and after surgery. Physicians managing such conditions are involved in the
overall care of the patient. Those with high or minimally responding IOP may benefit from
systemic carbonic anhydrase inhibitors or osmotic agents to further reduce the pressure before
the procedure is performed. Trabeculectomy can be done as an outpatient procedure in
selected cases, but, in most instances, due to the nature of the environment (long distance from
eye care facility; hostile, dirty and unhygienic situation of the living environment; and
illiteracy), patients often require inpatient care and are discharged within a week. POAG
surgery is usually performed under local anaesthesia using lignocaine-containing adrenaline
in appropriate dilution. General anaesthesia is administered where there is a need to do so.
4. The procedure: Trabeculectomy with anti-fibrotic agent
This is performed in the operating theatre under complete aseptic condition. The surgeon and
assistant are fully scrubbed and gowned. The skin around the eye is cleaned with povidone
iodine 5% which is also used to wet and subsequently flush the conjunctiva with normal saline;
adhesive drapes are placed leaving the globe area exposed. A wire speculum is used to part
the lids, the superior rectus muscle is picked with toothed forceps and 4/0 silk suture is passed
under it. A conjuctival flap is then raised. This can either be fornix or limbal based. Limbal-
based flap reduces risk of fibrosis over the filtration drainage site though some believe it allows
a freer connection of the surgical site with external conjuctiva and may in theory increase
infection risk. Proponents of fornix flap believe it offers greater wound closure and lower
infection risk. A caliper is used to demarcate proposed area to raise the outer sclera flap of 5
by 5 mm size. The area is cleared of tenons and haemostasis secured with bipolar wet field
cautery. Ideally a separate trolley is used for administration of antimetabolite. A 5% dilution
of mytomycin C or 5- fluorouracil is employed. A piece of cotton wool is soaked with the agent
and applied over the sclera flap site for five minutes and then washed with 50 millilitres of
normal saline. The trolley is subsequently taken away and the surgeons change gloves. The
outline of the outer sclera flap is demarcated gently with a scalpel. The proximal part is gently
elevated to form the lip of the partial thickness scleral flap. A chooks knife is then used to
bluntly dissect the flap from the base of the cornea. A smaller inner sclera flap of 3 by 3 mm is
then raised and excised. This is followed by a peripheral iridectomy. The outer flap is sutured
at the two proximal edges. Some clinicians prefer to suture all the 4 edges with 10/0 silk sutures.
The knots are buried in the sclera. The anterior chamber (A/C) is reformed with saline via a
cannula. Conjunctiva is sutured at the edges in fornix-based flap. A running suture with a knot
at the two ends can be used to close the conjunctiva in cases that had a limbal-based flap using
absorbable 6/0 vicryl. Subconjuctival dexamethasone 4 mg injection is given and tropicamide
eye drops applied before the eye is padded. First-day assessment includes measuring visual
acuity, IOP, wound site, bleb size and function. Slit lamp bio microscopy is essential in
determining state of the eye, such as cornea clarity, depth of A/C, in addition to fundoscopy.
Post-operative medications include steroid/antibiotic combination eye drops, a mydriatic and
systemic antibiotic such as amoxicillin. Initial follow-up visit is after one week.
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5. Complications of trabeculectomy
Intraoperative complication includes hemorrhage, which can be arrested and bleeding vessels
cauterized. Shallow A/C on the table usually reforms; in the event of delayed reformation,
saline can be injected after the outer sclera flap is sutured.
Post-operative complications include the following:
• Shallow A/C. This is of varied etiology. In case of excessive filtration, the bleb is formed;
there is no aqueous leakage as confirmed by a negative Seidel’s test and the IOP is not raised.
This can be managed by firm pressure padding and observation. In rare instances an
additional transconjuctival suture is applied. Wound leakage results in shallow A/C with
hypotony and positive Seidel’s test detected by dilution of instilled flourescein from the bleb
site on inspection with cobalt blue light on the slit lamp. This can be managed conservatively
by pressure padding and tends to improve. Failure to improve is addressed by applying
one or two additional sutures. Pupil block glaucoma arises from a non-functioning periph‐
eral iridectomy. There is shallow A/C, negative Seidel’s test, with raised IOP and iris bombe.
Laser iridotomy may be required to relieve the pressure. Malignant glaucoma arises from
aqueous back tracking behind the vitreous resulting in hypertony with markedly elevated
IOP, corneal edema and shallow A/C with flattened bleb. Management involves adminis‐
tration of systemic osmotic agents such as mannitol, or urea and intravenous carbonic
anhydrase inhibitors. In some instances Yag Laser is used to disrupt the anterior vitreous
face thus allowing the trapped aqueous to pass through the normal channel.
• Post-operative endophthalmitis. Early manifestation is within 24 to 48 hours. Patient has
pain and reduced vision with redness. This requires standard protocol of endophthalmitis
management such as aqueous/vitreous aspiration for microscopy culture and sensitivity.
Common pathogens are staphylococcus species. Relevant antibiotics are commenced
immediately topically, systemically and intra-cameral/intravitreal. Antibiotic can be
modified based on culture results.
• Other bleb-related complications include bleb failure which could arise from fibrosis or
formation of tenon cyst. Management includes ocular compression, suture manipulation
needling and, in some instances, injection of diluted 5-fluorouracil within the first two weeks
of surgery. Blebitis is characterized by inflammation and debris (exudates). Without
intraocular extension, the vision is normal. Treatment involves taking swab for microscopy,
culture and sensitivity. Topical ofloxacin and ciprofloxacin can be used. Large cystic
acellular bleb can leak. Mild to moderate leakage can be managed conservatively by
pressure padding and antibiotic prophylaxis. Persistent or large area of leakage may require
bleb revision such as advancing a conjuctival hood over it.
• Trabeculectomy can accelerate cataract formation. Cataract surgery should be through an
approach that does not tamper with bleb function.




POAG is a common cause of avoidable blindness in SSA. Due to socio-demographic reasons,
patients have poor access to eye care and often present late. Trabeculectomy with antimeta‐
bolite is an acceptable procedure that offers good IOP control. Proper education of the patient
and caregiver particularly on the goal of treatment is an essential component of management.
Author details
Lawan Abdu
Address all correspondence to: lawal1966@yahoo.com
Department of Ophthalmology, Faculty of Clinical Sciences, College of Health Sciences,
Bayero University Kano, Nigeria
References
[1] Cook C, Foster P. Epidemiology of glaucoma: what’s new? Can J Ophthalmol 2012
Jun; 47 (3): 223-6
[2] Abdu L. Prevalence and causes of blindness and low vision in Dambatta local gov‐
ernment area, Kano state, Nigeria. Niger J Med 2001 Jul-Sep; 11 (3): 108-12
[3] Murdoch IE, Cousens SN, Babalola OE, et al. Afri J Med Med Sci 2001 Dec; 30 (4):
337-9
[4] Adeoye A. Survey of blindness in rural communities of south-western Nigeria. Trop
Med Int Health 1996 Oct; 1 (5): 672-6
[5] Agbeja-Baiyeroju AM, Bekibele CO, Bamgboye EA, et al. The Ibadan glaucoma
study. Afr J Med Med Sci 2003 Dec; 32 (4): 371-6
[6] Omoti AE, Osahon AL, Waziri-Erameh MJ. Pattern of presentation of primary open
angle glaucoma in Benin City, Nigeria. Trop Doct 2006 Apr; 36 (2): 97-100
[7] Dawodu OA, Osahon AI, Emifoniye E. Prevalence and causes of blindness in Otib‐
hor Okhae Teaching Hospital, Irrua, Edo State, Nigeria. Ophthalmic Epidemiol 2003
Dec; 10 (5); 323-30
[8] Mohammed MA, Selvaraj S, Gudlavalleti VS, et al. Causes of blindness and visual
impairment in Nigeria: The Nigerian National Blindness and Visual Impairment Sur‐
vey. Invest Ophthalmol Vis Sci 2009 Sep; 50 (9): 4114-20
Advances in Eye Surgery110
[9] Ntim-Amponsah CT, Amoaku WM, Ofosu-Amaah S, et al. Prevalence of glaucoma in
an African country. Eye 2004 May; 18 (5): 491-7
[10] Nigerian population report. www.nationmaster.com/country/ni-nigeria/peo-people
accessed on 18/10/2014
[11] Osahon AL. Consequences of traditional eye medicine in U.B.T.H Benin City. Nig J
Ophthalmol 1995; 3: 51-54
[12] Awoyesuku EA, Ejimadu CS. Visual disability in newly diagnosed primary open an‐
gle glaucoma (POAG) in a tertiary hospital in Nigeria. Niger J Med 2012 Jan-March;
21 (1): 78-80
[13] Womald R, Foster A. Clinical and pathological features of chronic glaucoma in north-
east Ghana. Eye (Lond) 1990; 4 (Pt 1): 107-14
[14] Mafwiri M, Bowman RJ, Wood M, et al. Primary open angle glaucoma presentation
at a tertiary unit in Africa: intra ocular pressure levels and visual status. Ophthalmic
Epidemiol 2005 Oct; 12 (5):299-302
[15] Ayena KD, Agbo AD, Attaya AB, et al. [Characteristics of cup/disc ratios in a popula‐
tion of northern Togo aged 20-40 years]. J Fr Ophthalmol 2010 Jun; 33 (6): 408-13
[16] Kovin N, Stephen G, Maria-Gloria B, et al. Prevalence and causes of loss of vision in
sub- Saharan Africa 1990-2010. Br J Ophthalmol 2014; 98: 612-8
[17] Sonouvou I, Tchabi S, Monteiro S, et al. Therapeutic of primary open angle glaucoma
in Cotonou: a series of 224 cases. J Fr Ophthalmol 2012 Feb; 35 (2): 100-5
[18] Abdu L. Epidemiological properties of primary open angle glaucoma in Nigeria. J
Ophthalmol 2013; 2013: 402739.doi:10.1155/2013/402739
[19] Lawan A. Pattern of presentation and outcome of surgical management of primary
open angle glaucoma in Kan, Northern Nigeria. Ann Afr Med 2001 Dec; 6 (4): 180-5
[20] Adegbehingbe B, Majengbasan T. A review of trabeculectomies at a Nigerian teach‐
ing hospital. Ghana Med J 2007 Dec; 41 (4): 176-80
[21] Kim HY, Egbert PR, Singh K. Long- term comparison of primary Trabeculectomy
with 5-fluoracil versus mytomycin C in West Africa. J Glaucoma 2008 Oct-Nov; 17
(7): 578-83
[22] Anand N, Mielke C, Dawda VK. Trabeculectomy outcomes in advanced glaucoma in
Nigeria. Eye (Lond) 2001 Jun; 15 (Pt): 274-8
[23] Komolafe OO, Ashaye AO, Bekibele CO, et al. Outcome of Trabeculectomy with 5-
fluorouracil using releasable suture technique in a Nigerian Tertiary Hospital. West
Afr J Med 2011 May-Jun; 30 (3): 173-7
Primary Open Angle Glaucoma Surgery in Sub-Saharan African Setting — Benefits and Challenges
http://dx.doi.org/10.5772/60485
111

